FPGK
NVAX icon

Financial Partners Group (Kansas)’s Novavax NVAX Stock Holding History

Financial Partners Group (Kansas)’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-1,864
Closed -$396K – 162
2021
Q2 		$396K Buy
+1,864
New +$342K 0.1% 102

Other funds holding NVAX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Financial Partners Group (Kansas)'s NVAX Position: Q3 2021 in Review

Financial Partners Group (Kansas) sold out of Novavax (NVAX) in Q3 2021, closing a stake of 1,864 shares — an estimated $396K sold.

Financial Partners Group (Kansas) first reported a position in NVAX in Q2 2021 and held it in 1 quarter. The position peaked at $396K in Q2 2021. 443 funds tracked by Wall St. Rank hold NVAX as of Q3 2021.

  • Financial Partners Group (Kansas) reported no remaining Novavax position as of Q3 2021 after selling out during the quarter.
  • Financial Partners Group (Kansas) sold 1,864 Novavax shares in Q3 2021, an estimated $396K.
  • Financial Partners Group (Kansas) first reported a position in Novavax in Q2 2021 and held it in 1 quarter.
  • Financial Partners Group (Kansas)'s Novavax position peaked at $396K in Q2 2021.
  • 443 funds tracked by Wall St. Rank held Novavax as of Q3 2021.

Based on Financial Partners Group (Kansas)'s 13F filing for Q3 2021, filed 5 Nov 2021.